XOMA Corporation (XOMAP) Financial Analysis & Valuation | Quarter Chart
XOMA Corporation (XOMAP)
XOMAPPrice: $25.86
Fair Value: 🔒
🔒score
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have ... more
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and th... more
Description
Shares
| Market Cap | $312.39M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | US | CEO | Owen Hughes Jr. |
| IPO Date | 2020-12-16 | CAGR | 0.04% |
| Employees | 13 | Website | www.xoma.com |
| Div. Yield | — | Payout Ratio | -0.46% |
| Buy Back Yield | 0.96% | Total Yield | 0.96% |
XOMAP chart loading...
Fundamentals
Technicals
| Enterprise Value | $401.88M | P/E Ratio | 25.83 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 8.18 | P/B Ratio | 3.48 |
| P/CF Ratio | -111.04 | P/FCF Ratio | -109.83 |
| EPS | $1 | EPS Growth 1Y | -160.84% |
| EPS Growth 3Y | 21.69% | EPS Growth 5Y | -267.62% |
| Revenue Growth 1Y | 118.02% | Gross Margin | 0.97% |
| Operating Margin | -0.32% | Profit Margin | -0.31% |
| ROE | -0.14% | ROA | -0.05% |
| ROCE | -0.06% | Current Ratio | 4.88 |
| Quick Ratio | 4.88 | Cash Ratio | 3.5 |
| Debt/Equity | 1.24 | Interest Coverage | -0.91 |
| Altman Z Score | -4.56 | Piotroski Score | 4 |